Bionano Genomics, Inc. (BNGO)
1.185
-0.02
(-1.25%)
USD |
NASDAQ |
Mar 26, 12:15
Bionano Genomics Cash from Investing (Quarterly) : 4.009M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Bio-Rad Laboratories, Inc. | -34.20M |
| Bruker Corp. | -55.50M |
| Azenta, Inc. | 36.77M |
| Harvard Bioscience, Inc. | -0.599M |
| Avantor, Inc. | -39.70M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.175M |
| Cash from Financing (Quarterly) | 1.603M |
| Free Cash Flow | -16.34M |
| Free Cash Flow Per Share (Quarterly) | -0.3887 |
| Free Cash Flow to Equity (Quarterly) | -3.874M |
| Free Cash Flow to Firm (Quarterly) | -4.103M |
| Free Cash Flow Yield | -248.4% |